Mercantile Bank Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Mercantile Bank Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2022-12-31 | 2022-09-30 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2009-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||
net income | 19,626,000 | -62,104,783,000 | 20,855,000,000 | 21,803,000,000 | 16,031,000,000 | 11,639,000,000 | 15,051,000,000 | 14,082,000,000 | 10,686,000,000 | 3,454,000,000 | 4,016,000,000 | 4,400,000,000 | 3,991,000,000 | 2,880,000,000 | 30,323,000,000 | 15,947,913,000 |
adjustments to reconcile net income to net cash from operating activities | ||||||||||||||||
depreciation and amortization/accretion | ||||||||||||||||
benefit from credit losses | 1,500,000 | -5,892,300,000 | 3,300,000,000 | 3,050,000,000 | 2,900,000,000 | |||||||||||
stock-based compensation expense | 785,000 | -2,501,616,000 | 824,000,000 | 979,000,000 | 790,000,000 | 2,059,000,000 | 448,000,000 | 223,000,000 | 736,000,000 | 118,000,000 | 118,000,000 | 118,000,000 | 5,000,000 | 4,000,000 | -5,000,000 | -465,389,000 |
stock grants to directors for retainer fees | ||||||||||||||||
proceeds from sales of mortgage loans held for sale | 115,618,000 | -143,126,783,000 | 73,043,000,000 | 42,405,000,000 | 59,853,000,000 | 176,655,000,000 | 157,023,000,000 | 172,032,000,000 | 214,117,000,000 | 14,491,000,000 | 13,038,000,000 | 16,260,000,000 | 16,072,000,000 | 16,431,000,000 | 21,322,000,000 | -64,727,218,000 |
origination of mortgage loans held for sale | -98,412,000 | 144,681,273,000 | -68,798,000,000 | -30,149,000,000 | -59,468,000,000 | -138,674,000,000 | -169,891,000,000 | -159,309,000,000 | -189,266,000,000 | -12,764,000,000 | -12,990,000,000 | -15,393,000,000 | -15,683,000,000 | -17,066,000,000 | -18,846,000,000 | 64,691,749,000 |
net gain from sales of mortgage loans held for sale | -2,474,000,000 | -1,832,000,000 | -6,659,000,000 | -10,199,000,000 | -155,000,000 | -193,000,000 | -202,000,000 | -230,000,000 | -253,000,000 | |||||||
net gain from sales and valuation write-downs of foreclosed assets | 0 | 390,581,000 | -391,000,000 | -22,000,000 | -27,000,000 | -4,000,000 | 7,000,000 | -142,000,000 | 0 | |||||||
net gain from sale and write-down of former bank premises | ||||||||||||||||
earnings on bank owned life insurance | -497,000 | 1,222,500,000 | -422,000,000 | -368,000,000 | -238,000,000 | -292,000,000 | -298,000,000 | -281,000,000 | -290,000,000 | -337,000,000 | -350,000,000 | -338,000,000 | -385,000,000 | -407,000,000 | -437,000,000 | |
net (gain) loss on instruments designated at fair value and related derivatives | -351,000 | |||||||||||||||
net change in: | ||||||||||||||||
accrued interest receivable | 1,013,000 | 4,126,670,000 | -2,645,000,000 | -1,488,000,000 | -3,104,000,000 | 675,000,000 | -335,000,000 | 163,000,000 | -1,734,000,000 | -117,000,000 | 239,000,000 | -25,000,000 | 532,000,000 | -24,000,000 | 484,000,000 | -442,575,000 |
other assets | -1,564,000 | 12,984,811,000 | -11,677,000,000 | -30,000,000 | 11,342,000,000 | -910,000,000 | -6,270,000,000 | -4,623,000,000 | -1,503,000,000 | 1,521,000,000 | 9,771,000,000 | 2,159,000,000 | -628,000,000 | 629,000,000 | 172,000,000 | 9,423,593,000 |
accrued interest payable and other liabilities | 22,036,000,000 | 3,669,000,000 | 2,605,000,000 | 138,000,000 | ||||||||||||
net cash from (for) operating activities | ||||||||||||||||
cash flows from investing activities | ||||||||||||||||
loan originations and payments | -61,350,000 | 187,619,717,000 | -52,597,000,000 | -35,585,000,000 | -156,912,000,000 | -138,377,000,000 | -65,224,000,000 | 130,956,000,000 | -32,037,000,000 | -16,799,000,000 | -35,212,000,000 | 14,779,000,000 | -8,510,000,000 | 7,951,000,000 | 13,119,000,000 | |
purchases of securities available for sale | -69,095,000 | 12,997,059,000 | -1,376,000,000 | -15,811,000,000 | -12,560,000,000 | -40,741,000,000 | -89,061,000,000 | -99,563,000,000 | -81,489,000,000 | -8,519,000,000 | -13,989,000,000 | -14,984,000,000 | ||||
proceeds from maturities, calls and repayments of securities available for sale | 25,235,000 | -12,831,858,000 | 2,658,000,000 | 4,722,000,000 | 1,621,000,000 | 2,901,000,000 | 33,006,000,000 | 24,269,000,000 | 75,979,000,000 | 3,040,000,000 | 16,224,000,000 | 12,314,000,000 | ||||
proceeds from sales of foreclosed assets | 0 | -451,469,000 | 452,000,000 | 22,000,000 | 27,000,000 | 15,000,000 | 23,000,000 | 387,000,000 | 0 | 846,000,000 | 3,020,000,000 | 2,639,000,000 | 1,782,000,000 | 9,714,000,000 | ||
proceeds from sales of fomer bank premises | ||||||||||||||||
proceeds from bank owned life insurance claims | ||||||||||||||||
net purchases of premises and equipment and lease activity | -1,461,000,000 | -1,767,000,000 | -1,352,000,000 | -695,000,000 | ||||||||||||
net cash for investing activities | -102,961,000 | 196,655,068,000 | -51,726,000,000 | -52,003,000,000 | -166,597,000,000 | -179,071,000,000 | -121,686,000,000 | 53,561,000,000 | -40,319,000,000 | |||||||
cash flows from financing activities | ||||||||||||||||
net increase in time deposits | 66,107,000 | -281,873,219,000 | 54,765,000,000 | -33,905,000,000 | -1,308,000,000 | 160,847,731,000 | ||||||||||
net increase in all other deposits | 176,361,000 | -129,324,000,000 | -52,561,000,000 | 220,872,000,000 | 218,981,000,000 | 73,424,000,000 | 111,062,000,000 | 22,457,000,000 | -22,983,000,000 | 702,000,000 | 11,428,000,000 | 5,467,000,000 | 4,157,000,000 | -12,438,679,000 | ||
net increase in securities sold under agreements to repurchase | 30,293,394,000 | -55,375,000,000 | -4,265,000,000 | -4,734,000,000 | 21,613,000,000 | 6,113,000,000 | -38,652,000,000 | -10,510,000,000 | 3,979,000,000 | 3,229,000,000 | -8,428,658,000 | |||||
payoffs and paydowns of federal home loan bank advances | ||||||||||||||||
proceeds from federal home loan bank advances | 0 | -199,760,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,000,000,000 | 0 | 0 | 10,000,000,000 | 10,000,000,000 | -4,995,000,000 | |
employee stock purchase plan | 15,000 | -32,955,000 | 10,000,000 | 12,000,000 | 12,000,000 | 13,000,000 | 13,000,000 | 12,000,000 | 12,000,000 | 0 | 10,000,000 | 9,000,000 | 11,000,000 | 9,000,000 | 12,000,000 | -42,943,000 |
dividend reinvestment plan | 201,000 | -669,109,000 | 221,000,000 | 214,000,000 | 218,000,000 | 229,000,000 | 237,000,000 | 204,000,000 | 206,000,000 | 0 | 17,000,000 | 16,000,000 | 0 | -8,989,000 | ||
payment of cash dividends to common shareholders | -5,702,000 | 15,640,996,000 | -5,330,000,000 | -4,995,000,000 | -4,978,000,000 | -4,644,000,000 | -4,660,000,000 | -4,494,000,000 | -4,474,000,000 | -1,037,000,000 | -950,000,000 | -864,000,000 | 508,406,000 | |||
net cash from financing activities | 283,466,000,000 | 190,526,000,000 | -3,717,000,000 | 94,988,000,000 | ||||||||||||
net change in cash and cash equivalents | 64,464,000 | -169,181,239,000 | 58,191,000,000 | -187,242,000,000 | -195,091,000,000 | 65,830,000,000 | 83,364,000,000 | 67,941,000,000 | -56,800,000,000 | -21,226,000,000 | -2,542,000,000 | 8,636,000,000 | -49,331,000,000 | -40,875,069,000 | ||
cash and cash equivalents at beginning of period | 0 | -96,675,228,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 136,003,000,000 | 0 | 76,372,000,000 | 0 | -25,778,196,000 | ||
cash and cash equivalents at end of period | 64,464,000 | -265,856,467,000 | 58,191,000,000 | -187,242,000,000 | -195,091,000,000 | 65,830,000,000 | 83,364,000,000 | 67,941,000,000 | -56,800,000,000 | 114,777,000,000 | -2,542,000,000 | 85,008,000,000 | -49,331,000,000 | -66,653,265,000 | ||
supplemental disclosures of cash flows information | ||||||||||||||||
cash paid during the period for: | ||||||||||||||||
interest | 34,193,000 | -48,591,976,000 | 20,626,000,000 | 6,393,000,000 | 6,592,000,000 | 5,243,000,000 | 6,649,000,000 | 2,711,000,000 | 2,729,000,000 | 3,339,000,000 | 3,285,000,000 | 4,420,000,000 | 6,239,000,000 | -49,571,337,000 | ||
federal income tax | 4,740,000,000 | 800,000,000 | 2,300,000,000 | 2,650,000,000 | 0 | 0 | 0 | 0 | 0 | |||||||
depreciation and amortization | 2,358,000 | -8,845,504,000 | 2,927,000,000 | 3,090,000,000 | 3,163,000,000 | 3,478,000,000 | 3,445,000,000 | 3,163,000,000 | 2,877,000,000 | 543,000,000 | 533,000,000 | 553,000,000 | 578,000,000 | 510,000,000 | 506,000,000 | -2,169,423,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||
deferred income tax benefit | ||||||||||||||||
net gain on sales of mortgage loans held for sale | 712,095,000 | |||||||||||||||
income from sale of mortgage loans | ||||||||||||||||
net (gain) income from sale and write-downs on former bank premises | ||||||||||||||||
net (gain) income from sales and disposals of premises and equipment | ||||||||||||||||
accrued interest and other liabilities | ||||||||||||||||
net cash from operating activities | 59,858,000 | -73,845,387,000 | 36,445,000,000 | 37,069,000,000 | 32,796,000,000 | 45,404,000,000 | 21,571,000,000 | 5,517,000,000 | 13,152,000,000 | 3,299,000,000 | 5,034,000,000 | 2,934,000,000 | ||||
proceeds from sale of mortgage loans | ||||||||||||||||
proceeds from federal home loan bank stock redemption | 0 | 0 | 0 | 0 | ||||||||||||
purchases of federal home loan bank stock | 0 | 3,788,208,000 | 0 | 0 | 0 | |||||||||||
purchases of bank owned life insurance | -700,000,000 | 0 | 1,006,882,000 | |||||||||||||
proceeds from bank owned life insurance death benefits claim | 0 | 0 | 0 | 0 | 0 | |||||||||||
purchases of premises and equipment and lease activity | ||||||||||||||||
proceeds from sales of former bank premises | 0 | -597,402,000 | 0 | 2,994,000,000 | 483,000,000 | 265,000,000 | 0 | 0 | ||||||||
maturities of federal home loan bank advances | -30,000,000 | 50,272,647,000 | -10,000,000,000 | -30,000,000,000 | -24,000,000,000 | -20,000,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | -10,000,000,000 | 49,930,000,000 | ||
net proceeds from subordinated notes issuance | 0 | 0 | 0 | 0 | ||||||||||||
proceeds from stock option exercises, net of cashless exercises | 0 | 0 | 0 | 0 | 0 | |||||||||||
net cash (for) from financing activities | -291,990,920,000 | 73,472,000,000 | -172,308,000,000 | -61,290,000,000 | ||||||||||||
cash paid during the year for: | ||||||||||||||||
federal income taxes | ||||||||||||||||
noncash financing and investing activities: | ||||||||||||||||
transfers from loans to foreclosed assets | 0 | -111,888,000 | 51,000,000 | 0 | 0 | 0 | 135,000,000 | 350,000,000 | 63,000,000 | 1,647,000,000 | 775,000,000 | 8,096,000,000 | 1,644,000,000 | |||
transfers from bank premises to other real estate owned | 0 | -599,200,000 | 0 | 179,000,000 | ||||||||||||
transfers from premises and equipment to other assets | 0 | 0 | 0 | 0 | ||||||||||||
stock grants to directors for retainer fee | -316,650,000 | 0 | 12,000,000 | 0 | 0 | 0 | 0 | 45,000,000 | ||||||||
net gain from sales and valuation write-downs of former bank premises | 0 | |||||||||||||||
net income from sales and write-downs of fixed assets | 0 | 0 | ||||||||||||||
net decrease in securities sold under agreements to repurchase | -4,609,000,000 | -15,129,000,000 | ||||||||||||||
net increase in federal funds purchased | ||||||||||||||||
payoffs of and paydowns on federal home loan bank advances | ||||||||||||||||
accretion of acquired loans | 0 | 0 | -33,000,000 | -34,000,000 | -112,000,000 | -112,000,000 | ||||||||||
deferred income tax expense | ||||||||||||||||
gain on sale of branch | 0 | 0 | 0 | 0 | ||||||||||||
net cash transferred in branch sale | 0 | 0 | 0 | 0 | ||||||||||||
repurchases of common stock | ||||||||||||||||
net income from sales and valuation write-downs of former bank premises | 275,000,000 | |||||||||||||||
net gain from sales and write-downs of fixed assets | ||||||||||||||||
net gain on instruments designated at fair value and related derivatives | ||||||||||||||||
net decrease in all other deposits | 89,181,000,000 | |||||||||||||||
net (gain) income from sales and write-downs of fixed assets | ||||||||||||||||
net change in federal funds purchased | ||||||||||||||||
net proceeds from stock option exercises | ||||||||||||||||
proceeds from subordinated notes issuance | ||||||||||||||||
net cash from (for) financing activities | 167,482,139,000 | |||||||||||||||
net decrease in time deposits | -3,950,000,000 | 24,753,000,000 | -21,261,000,000 | 37,737,000,000 | -8,492,000,000 | -43,116,000,000 | 768,000,000 | -24,108,000,000 | -77,415,000,000 | |||||||
change in fair value of derivative asset | ||||||||||||||||
change in fair value of derivative liability | ||||||||||||||||
repurchases of common stock shares | 0 | -8,947,000,000 | 0 | |||||||||||||
payoffs of federal home loan bank advances | ||||||||||||||||
benefit from loan losses | -3,400,000,000 | 1,900,000,000 | 2,500,000,000 | 3,200,000,000 | -1,700,000,000 | -1,500,000,000 | -1,500,000,000 | -3,000,000,000 | 0 | 1,900,000,000 | ||||||
net gain from sale and write-downs on former bank premises | ||||||||||||||||
net income from sales and disposals of premises and equipment | ||||||||||||||||
proceeds from bank owned life insurance cash value release and death benefits | 0 | 0 | ||||||||||||||
mercantile bank corporation | ||||||||||||||||
consolidated statements of cash flows | ||||||||||||||||
years ended december 31, 2021, 2020 and 2019 | ||||||||||||||||
net (gain) income from sales and valuation write-downs of former bank premises | -2,000,000 | |||||||||||||||
proceeds from stock option exercises | 0 | 0 | 18,000,000 | 0 | ||||||||||||
net cash (for) from operating activities | ||||||||||||||||
net cash for operating activities | ||||||||||||||||
net purchases of premises and equipment | -2,772,000,000 | |||||||||||||||
purchases of premises and equipment | -116,000,000 | -54,000,000 | -80,000,000 | -67,000,000 | -70,000,000 | -334,000,000 | 28,956,000 | |||||||||
years ended december 31, 2020, 2019 and 2018 | ||||||||||||||||
net cash from/(for) operating activities | ||||||||||||||||
net gain from sales of available for sale securities | ||||||||||||||||
proceeds from sales of securities available for sale | 6,405,000,000 | |||||||||||||||
years ended december 31, 2019, 2018 and 2017 | ||||||||||||||||
net (gain) income from sale and valuation write-down of foreclosed assets | -129,000,000 | -367,000,000 | -528,000,000 | |||||||||||||
accrued expenses and other liabilities | 592,000,000 | 837,000,000 | -2,205,000,000 | 2,828,000,000 | 72,000,000 | |||||||||||
net cash from (for) investing activities | -15,143,000,000 | -203,905,433,000 | ||||||||||||||
net increase in other borrowed money | 58,000,000 | -32,000,000 | 81,000,000 | |||||||||||||
repurchase of preferred stock | 0 | |||||||||||||||
repurchase of common stock warrant | ||||||||||||||||
payment of cash dividends on preferred stock | 0 | 0 | 0 | -99,000,000 | -263,000,000 | -1,620,000,000 | 262,475,000 | |||||||||
net cash for financing activities | 77,567,000,000 | -43,846,000,000 | -39,193,000,000 | -23,492,000,000 | -34,026,000,000 | -71,917,000,000 | ||||||||||
net cash from investing activities | 14,668,000,000 | 15,916,000,000 | 39,728,000,000 | 15,723,000,000 | ||||||||||||
preferred stock cash dividend accrued | 0 | -134,000,000 | 134,000,000 | -1,354,000,000 | -133,866,000 | |||||||||||
adjustments to reconcile net income to net cash from (for) operating activities: | ||||||||||||||||
net gain on sale of mortgage loans held for sale | ||||||||||||||||
net gain on sale of held to maturity securities | ||||||||||||||||
gain on sale of commercial loans | ||||||||||||||||
net (gain) loss on sale and write-down of premises and equipment | ||||||||||||||||
net income on sale and valuation write-downs of foreclosed assets | ||||||||||||||||
recognition of unrealized gain on interest rate swaps | 0 | 1,548,197,000 | ||||||||||||||
purchases of: | ||||||||||||||||
securities available for sale | -4,008,000,000 | -17,985,000,000 | -25,763,000,000 | 39,910,941,000 | ||||||||||||
proceeds from: | ||||||||||||||||
maturities, calls and repayments of securities available for sale | ||||||||||||||||
proceeds from sale of held to maturity securities | ||||||||||||||||
proceeds from sale of commercial loans | ||||||||||||||||
proceeds from sale of foreclosed assets | ||||||||||||||||
maturities and prepayments of federal home loan bank advances | 0 | |||||||||||||||
maturities of wholesale repurchase agreements | 0 | |||||||||||||||
supplemental disclosures of cash flow information | ||||||||||||||||
net income from sale and valuation write-down of foreclosed assets | 954,000,000 | 158,000,000 | ||||||||||||||
maturities, calls and repayments of available for sale securities | 26,719,000,000 | 40,118,000,000 | ||||||||||||||
redemption of federal home loan bank stock | ||||||||||||||||
net decrease in other borrowed money | 9,000,000 | -20,000,000 | ||||||||||||||
securities held to maturity | 1,023,975,000 | |||||||||||||||
maturities, calls and repayments of securities held to maturity | ||||||||||||||||
decrease in other borrowed money | ||||||||||||||||
proceeds from issuance of preferred stock and common stock warrant | ||||||||||||||||
gain from sale of commercial loans | ||||||||||||||||
net gain from sale of held to maturity securities | ||||||||||||||||
sales of held to maturity securities | ||||||||||||||||
proceeds from sales of commercial loans | ||||||||||||||||
net decrease in federal funds purchased | ||||||||||||||||
payment of cash dividends on common shares | ||||||||||||||||
benefit from loan and lease losses | -33,641,000,000 | |||||||||||||||
federal home loan bank stock | 0 | |||||||||||||||
loan and lease originations and payments | -185,690,709,000 | |||||||||||||||
increase in structured repurchase agreements | ||||||||||||||||
maturities of structured repurchase agreements | ||||||||||||||||
increase in other borrowed money | ||||||||||||||||
transfers from loans and leases to foreclosed assets | -18,409,683,000 | |||||||||||||||
maturities, calls and repayments of held to maturity securities | ||||||||||||||||
cash paid in lieu of fractional shares on stock dividend | ||||||||||||||||
stock option exercises | ||||||||||||||||
net income on sale and write-down of foreclosed assets | ||||||||||||||||
earnings on bank owned life insurance policies | ||||||||||||||||
proceeds from the sales of commercial loans | ||||||||||||||||
proceeds from the sale of foreclosed assets | ||||||||||||||||
proceeds from issuance of preferred stock and common stock warrants | ||||||||||||||||
net gain on sales of mortgage loans | ||||||||||||||||
pay-offs of federal home loan bank advances | ||||||||||||||||
payment of cash dividend | ||||||||||||||||
net gain on sales of commercial loans | ||||||||||||||||
loss on sale of foreclosed assets | ||||||||||||||||
purchases of bank owned life insurance policies | ||||||||||||||||
pay-off of federal home loan bank advances | ||||||||||||||||
cash dividends | ||||||||||||||||
proceeds from the sale of mortgage loans held for sale | ||||||||||||||||
cash flows for investing activities | ||||||||||||||||
net increase in deposits | ||||||||||||||||
payment of cash dividends | ||||||||||||||||
proceeds from sale of mortgage loans held for sale | ||||||||||||||||
net decrease in deposits | ||||||||||||||||
benefit from deferred income taxes | ||||||||||||||||
federal home loan bank stock dividends | ||||||||||||||||
redemption of fhlb stock | ||||||||||||||||
cash flows for financing activities | ||||||||||||||||
loan and leases originations and payments | ||||||||||||||||
gain on sales of commercial loans | ||||||||||||||||
equity in undistributed income of subsidiary | ||||||||||||||||
equity compensation expense | ||||||||||||||||
change in other assets | ||||||||||||||||
change in other liabilities | ||||||||||||||||
net capital investment into subsidiaries | ||||||||||||||||
proceeds from the issuance of subordinated debentures | ||||||||||||||||
pay-off of subordinated debentures | ||||||||||||||||
fractional shares paid |
We provide you with 20 years of cash flow statements for Mercantile Bank stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Mercantile Bank stock. Explore the full financial landscape of Mercantile Bank stock with our expertly curated income statements.
The information provided in this report about Mercantile Bank stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.